THE POLICY EDGE
Reports/Data Releases

10 October 2026

NMC Restricts Misleading Medical Ads, Paid Rankings and AI-Generated Testimonials

Guidelines effective from 6 October 2026 apply to doctors and medical institutions across social media, search results, healthcare platforms and conventional advertising. They prohibit deceptive promotion while allowing factual information about services and non-promotional health education

Reports/Data Releases image

Key Details

The National Medical Commission’s Guidelines on Ethical Advertising and Public Communication by Hospitals/Medical Institutions and Registered Medical Practitioners set out what doctors and institutions may say publicly — and how breaches may be addressed.

  • Misleading claims: Unverifiable promises such as “guaranteed cure” or “100% success” are prohibited. Superiority claims and rankings must be objectively verifiable, with relevant methodology and conditions disclosed.

  • Patient promotion: Fake or paid reviews, promotional testimonials, before-and-after images and manipulated ratings are prohibited. Patient consent alone does not make an otherwise prohibited testimonial permissible.

  • Digital and AI content: AI must not be used to fabricate patient experiences, images, voices or clinical outcomes. Where permitted AI-generated promotional content is used, the guidelines require its origin to be identified.

  • Inducements and referrals: Discounts, coupons and similar offers must not encourage unnecessary care or solicit patients. Payment arrangements tied to procuring or referring individual patients are barred.

  • Permitted information: Hospitals may publish verifiable details of their facilities, services, accreditation and charges. Doctors may provide non-promotional health education and make specified factual announcements about their practice.

  • Enforcement: State Medical Councils may consider graded action against doctors, subject to a show-cause notice and an opportunity to respond. Separate applicable laws govern action against institutions.


Medical Advertising Rules Now Address Digital Patient Acquisition

The guidelines extend ethical scrutiny to sponsored posts, influencer promotions, search rankings, online healthcare platforms and AI-assisted content. A doctor or institution cannot avoid responsibility merely by publishing authorised promotional material through an agency or intermediary.

The distinction is between information patients can assess and promotion designed to win their business through unverifiable claims or inducements. A hospital can describe its equipment or publish its charges; it cannot turn those facts into a guarantee of treatment success. Healthcare platforms hosting doctors must also maintain transparent listings and comply with the prohibition on paid rankings.

Patient Consent Does Not Settle the Advertising Question

Patient privacy and advertising ethics are treated as separate requirements. Identifiable patient information generally requires the applicable legal safeguards and consent before use. But consent does not override a ban on a promotional testimonial, success story or before-and-after depiction that is otherwise prohibited.

The AI provisions follow the same logic. The guidelines target fabricated or misleading representations, including synthetic endorsements presented as real. They also address disclosure when the artificial origin of otherwise permitted content could matter to how an audience understands it. This is not a blanket ban on all AI-generated healthcare communication.

Enforcement Differs for Doctors and Institutions

For registered medical practitioners, the guidelines describe a possible progression from a warning and ethics training to censure, monetary penalty or suspension; repeated violations may lead to removal from the medical register for a specified period. These are measures a State Medical Council may consider, not automatic penalties for every breach. The doctor must receive notice and an opportunity to respond, and an appeal route is provided.

Hospitals and medical institutions are dealt with under the applicable clinical-establishment or state law. A doctor personally responsible for prohibited institutional communication may also face professional-conduct scrutiny.


Policy Relevance

The guidelines give patients a clearer basis for distinguishing verifiable service information from marketing claimswhen choosing care online. They also place practical responsibilities on doctors, hospitals and healthcare platforms to review how listings, testimonials, rankings and promotional campaigns are produced.

For regulators, the consequential task is consistent enforcement across channels and states: the same claim may appear on a hospital website, an influencer’s account and a third-party booking platform. The notice sets standards and procedures, but does not itself establish how often misleading promotion occurs or whether the new rules will reduce it.


Follow the Full Public Notice Here: NMC Guidelines on Ethical Advertising and Public Communication

Rethinking Public Policy Through Insight | Inquiry | Impact

Opinion • Grassroots Voices • Policymakers Perspectives • Expert Analysis • Policy Briefs